Rod J. Hughes
Nepean Blue Mountains Local Health District, 288-292 Macquarie Road
Springwood, NSW 2777, Australia
Springwood, NSW 2777, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.
Journal: The European respiratory journal
Published: November 28, 2025
Phenotyping Asthma and/or COPD Using 129Xe MRI and Comprehensive Physiologic Testing.
Journal: American journal of respiratory and critical care medicine
Published: October 10, 2025
Allergic sensitization in asthma and COPD in the NOVELTY study.
Journal: Respiratory medicine
Published: September 18, 2025
Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY Cohort.
Journal: Annals of the American Thoracic Society
Published: September 17, 2025
Participant Experience, Acceptability and Feasibility of Virtual and Digitally Supported Visits in a Phase IIa COPD Trial.
Journal: Journal of patient experience
Published: September 03, 2025
Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.
Journal: BMJ open respiratory research
Published: July 04, 2025
First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor.
Journal: The Journal of allergy and clinical immunology
Published: June 25, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.
Journal: British journal of clinical pharmacology
Published: April 01, 2025
ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.
Journal: Respiratory research
Published: March 31, 2025
Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO).
Journal: International journal of chronic obstructive pulmonary disease
Published: March 20, 2025
Phenotyping asthma and/or chronic obstructive pulmonary disease using 129Xe MRI and comprehensive physiologic testing.
Journal: American journal of respiratory and critical care medicine
Published: January 29, 2025
Validity of the Chronic Airways Assessment Test (CAAT) in asthma, asthma+COPD and COPD in NOVELTY.
Journal: ERJ open research
Published: December 17, 2024
Last Updated: 09/26/2026